Guided Therapeutics, Inc.
GTHP
$0.25
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -48.72% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -48.72% | -- | |||
| Cost of Revenue | -34.21% | -- | |||
| Gross Profit | -55.70% | -- | |||
| SG&A Expenses | -45.84% | 108.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -38.07% | 112.56% | |||
| Operating Income | 36.44% | -84.30% | |||
| Income Before Tax | 8.51% | -89.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.51% | -89.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.51% | -89.93% | |||
| EBIT | 36.44% | -84.30% | |||
| EBITDA | 36.45% | -84.47% | |||
| EPS Basic | 11.93% | -60.29% | |||
| Normalized Basic EPS | 23.08% | -71.05% | |||
| EPS Diluted | 8.26% | -9.00% | |||
| Normalized Diluted EPS | 23.08% | -71.05% | |||
| Average Basic Shares Outstanding | 3.62% | 15.44% | |||
| Average Diluted Shares Outstanding | 3.62% | 15.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||